[26]Faujdar J,Gupta P,Natrajan M,et al.Mycobacterium indicuspranii as stand-alone or adjunct immunotherapeutic in treat-ment of experimental animal tuberculosis.Indian J Med Res,2011,134(5):696-703.
[27]Ma Y,Chen HD,Wang Y,et al.Interleukin 24as a novel po-tential cytokine immunotherapy for the treatment of Mycobacte-rium tuberculosis infection.Microbes Infect,2011,13(12/13):1099-1100.
[28]Rosas-Taraco AG,Higgins DM,Sánchez-Campillo J,et al.Local pulmonary immunotherapy with siRNA targeting TGFβ1enhances antimicrobial capacity in Mycobacterium tuberculosisinfected mice.Tuberculosis(Edinb),2011,91(1):98-106.[29]Okada M,Kita Y,Nakajima T,et al.A novel therapeutic andprophylactic vaccine against tuberculosis using the cynomolgusmonkey model and mouse model.Procedia Vaccinol,2011,(4):42-49.
[30]Kita Y,Okada M,Nakajima T,et al.Development of thera-peutic and prophylactic vaccine against Tuberculosis usingmonkey and transgenic mice models.Hum Vaccin,2011,7Suppl:108-114.
[31]Okada M,Kita Y,Nakajima T,et al.Novel therapeutic vac-cine:granulysin and new DNA vaccine against Tuberculosis.Hum Vaccin,2011,7Suppl:60-67.
[32]Okada M,Kita Y,Nakajima T,et al.Novel prophylactic vac-cine using aprime-boost method and hemagglutinating virus ofJapan-envelope against tuberculosis.Clin Dev Immunol,2011:549281.
[33]Van Dissel JT,Soonawala D,Joosten SA,et al.Ag85B-ESAT-6adjuvanted with IC31?promotes strong and long-lived Myco-bacterium tuberculosis specific T cell responses in volunteerswith previous BCG vaccination or tuberculosis infection.Vac-cine,2011,29(11):2100-2109.
[34]Aagaard C,Hoang T,Dietrich J,et al.A multistage tuberculo-sis vaccine that confers efficient protection before and after ex-posure.Nat Med,2011,17(2):189-194.
[35]Yuan W,Dong N,Zhang L,et al.Immunogenicity and protec-tive efficacy of a tuberculosis DNA vaccine expressing a fusionprotein of Ag85B-Esat6-HspX in mice.Vaccine,2011,30(14):2490-2497.
[36]Li Q,Yu H,Zhang Y,et al.Immunogenicity and protectiveefficacy of a fusion protein vaccine consisting of antigen Ag85Band HspX against Mycobacterium tuberculosis infection in mice.
Scand J Immunol,2011,73(6):568-576.
[37]Niu H,Hu L,Li Q,et al.Construction and evaluation of a mul-tistage Mycobacterium tuberculosis subunit vaccine candidateMtb10.4-HspX.Vaccine,2011,29(51):9451-9458.
[38]Desel C,Dorhoi A,Bandermann S,et al.Recombinant BCGΔureC hly+induces superior protection over parental BCG bystimulating a balanced combination of type 1and type 17cyto-kine responses.J Infect Dis,2011,204(10):1573-1584.
[39]Ansari MA,Zubair S,Mahmood A,et al.RD antigen basednanovaccine imparts long term protection by inducing memoryresponse against experimental murine tuberculosis.PLoS One,2011,6(8):e22889.
[40]梁爱军.纤支镜下局部注药治疗复治肺结核疗效观察.中国误诊学杂志,2011,11(1):99-100.
[41]林霏申,陈珊珊,于俊,等.纤维支气管镜下钳夹加注药治疗支气管结核223例疗效观察.临床肺科杂志,2011,16(8):1219-1221.
[42]杜荣辉,曹探赜,连展,等.CT引导下空洞内注药在耐多药肺结核患者治疗中的作用.临床内科杂志,2011,28(7):1324-1326.
[43]吕康言,刘桑,岳静.经皮肺穿刺空洞内置管注药治疗耐多药空洞肺结核疗效观察.临床肺科杂志,2011,16(10):1550-1551.
[44]王鹏,马秋野,钟殿海.经纤维支气管镜腔内注药治疗难治性肺结核.中国实用医刊,2011,38(10):76.
[45]张杰,王娟,王婷.良性瘢痕增生性气道狭窄经气管镜介入治疗方法的初步研究.中华结核和呼吸杂志,2011,34(5):334-338.[46]傅瑜.重视支气管结核的综合及介入治疗.中华结核和呼吸杂志,2011,34(5):325-326.
[47]Lee SH,Choi WJ,Sung SW,et al.Endoscopic cryotherapy oflung and bronchial tumors:a systematic review.Korean J In-tern Med,2011,26(2):137-144.
[48]陈志,张广宇,梁建琴,等.氩等离子体凝固和冷冻序贯治疗支气管结核.中国防痨杂志,2011,33(2):213-215.
[49]Mu D,Nan D,Li W,et al.Efficacy and safety of bronchoscop-ic cryotherapy for granular endobronchial tuberculosis.Respi-ration,2011,82(3):268-272.
[50]李奕,姚小鹏,白冲,等.结核性主支气管重度狭窄合并单侧肺不张患者支气管镜介入治疗效果分析.中华结核和呼吸杂志,2011,34(6):454-458.
[51]刘伟,傅恩清,谢永宏,等.气管镜介入治疗支气管内膜结核方法的探讨.中华肺部疾病杂志(电子版),2011,4(3):183-186.[52]方勇,沙巍.气管镜下高压球囊扩张术治疗结核性气管狭窄一例并文献复习.中华临床医师杂志(电子版),2011,5(10):3084-3087.
[53]Soares Pires F,Teixeira N,Coelho F,et al.Hemoptysis—etiology,evaluation and treatment in a university hospital.Rev Port Pneumol,2011,17(1):7-14.
[54]Pierce G,Ahuja C,Chadha M.Case report:Complex internalmammary to pulmonary artery fistula as a cause of hemoptysisin tuberculosis:Diagnosis and endovascular management usingethylene vinyl alcohol copolymer(Onyx).Indian J Radiol Ima-ging,2011,21(1):10-12.
[55]Yoo DH,Yoon CJ,Kang SG,et,al.Bronchial and nonbron-chial systemic artery embolization in patients with major he-moptysis:safety and efficacy of N-butyl cyanoacrylate.AJRAm J Roentgenol,2011,196(2):W199-204.
[56]Karmakar S,Nath A,Neyaz Z,et al.Bronchial artery aneu-rysm due to pulmonary tuberculosis:detection with multide-tector computed tomographic angiography.J Clin Imaging Sci,2011,1:26.
[57]陆文彬,刘霆,孙松,等.支气管动脉栓塞治疗大咯血的临床应用.影像诊断与介入放射学,2011,20(2):128-129.
[58]Marchetti GP,Pinelli V,Tassi GF.100years of thoracosco-py:historical notes.Respiration,2011,82(2):187-192.[59]LüG,Wang B,Li J,et,al.Anterior debridement and recon-struction via thoracoscopy-assisted mini-open approach for the
·
0
7
4
·中国防痨杂志2012年7月第34卷第7期 Chin J Antituberc,July 2012,Vol.34,No.7
treatment of thoracic spinal tuberculosis:minimum 5-year fol-low-up.Eur Spine J,2012,21(3):463-469.

